37 documentos com tag com "Severity"

Automated inflammatory lesion counting, spatial density measurement, and IGA scoring for acne clinical trials. AI-powered endpoints aligned with FDA guidance.

Objective, reproducible dermatological endpoint scoring from smartphone images. Automated severity scoring aligned with established clinical scales for clinical trials. CE-marked Class IIa medical device.

Automated SALT scoring for alopecia clinical trials. AI-powered measurement of scalp hair loss across the four SALT quadrants from standardised photographs. CE-marked medical device.

Automated SCORAD and EASI scoring for atopic dermatitis clinical trials. AI-powered automated SCORAD and EASI severity assessment across body areas, validated in JID Innovations (2022). CE-marked medical device.

Evidence behind automated SALT scoring for alopecia, covering the validation of the hair loss segmentation model, the DIQA image quality gate, conference presentations, and the foundational SALT references.

Peer-reviewed publications behind automated SCORAD and EASI scoring for atopic dermatitis, including the primary automated-SCORAD study and the foundational SCORAD and EASI references.

Peer-reviewed publication behind automated IHS4 scoring for hidradenitis suppurativa, covering the AIHS4 study, the DIQA image quality gate, and the foundational IHS4 and HiSCR references.

Peer-reviewed publications and production validation behind automated PASI scoring for psoriasis, covering the peer-reviewed validation study, the DIQA image quality gate, and per-component performance against expert inter-rater variability.

Performance validation of acne severity endpoints, covering how the ground truth is established, what the metrics mean, ALADIN vs. dermatologist agreement, lesion detection performance, and the regulatory evidence pathway.

Legit.Health AI scoring is deployed in Phase 2 and Phase 3 clinical trials with top-10 pharma companies across 130+ sites in 12+ countries, spanning psoriasis, acne, alopecia, and atopic dermatitis.

End-to-end clinical trial workflow for acne severity endpoints, covering protocol design, patient enrollment, image capture, AI scoring, severity tracking, data export, EDC integration, and decentralised trial support.

End-to-end clinical trial workflow for SALT endpoints, covering protocol design, site setup, patient enrolment, in-clinic scalp capture, automated SALT scoring, change from baseline and alerts, data export, and EDC integration.

End-to-end clinical trial workflow for atopic dermatitis severity endpoints, covering protocol design, patient enrolment, image capture, AI scoring, severity tracking, data export, and EDC integration.

End-to-end workflow for cutaneous lupus erythematosus severity endpoints, covering retrospective image analysis versus prospective CLASI reconstruction, protocol design, capture, scoring, review, longitudinal tracking, and EDC data export.

End-to-end clinical trial workflow for hidradenitis suppurativa severity endpoints, covering protocol design, site setup, patient enrolment, in-clinic image capture, automated IHS4 and HiSCR, and EDC data export.

End-to-end clinical trial workflow for PASI endpoints, covering protocol design, site setup, patient enrolment, image capture, AI scoring, PASI response milestones, data export, and EDC integration.

Automated CLASI scoring for cutaneous lupus erythematosus clinical trials. AI quantification of the visual components of CLASI Activity and CLASI Damage across 13 anatomical regions, plus a continuous repigmentation measure, from smartphone images. CE-marked medical device.

Automated IHS4 and HiSCR for hidradenitis suppurativa clinical trials. AI detection and classification of inflammatory nodules, abscesses and draining tunnels, confirmed by the investigator. CE-marked medical device.

How atopic dermatitis images are captured for automated SCORAD and EASI scoring: the standard body-perspective and close-up set, DIQA quality control, patient preparation, and site standardisation.

How psoriasis images are captured for automated PASI scoring: the standard body-perspective and close-up set, DIQA quality control, patient preparation, and site standardisation.

Image capture protocol for cutaneous lupus erythematosus clinical trials, covering the 13-region CLASI capture set, target lesions, the metadata required to assemble a CLASI score, DIQA quality control, colour and scale calibration for erythema, pigmentation and lesion area, and facial anonymization.

Transparent documentation of what the AI acne severity scoring can and cannot do, including scope boundaries, validation gaps, and how each limitation is managed.

Transparent documentation of what the AI alopecia severity scoring can and cannot do, including segmentation challenges, validation status, and how each limitation is managed.

Transparent documentation of what the automated SCORAD and EASI scoring can and cannot do, including the inherent constraints of photograph-based assessment and how each limitation is managed.

Transparent documentation of what AI CLASI component scoring can and cannot do in cutaneous lupus erythematosus, covering the items not derived from an image, the scarring and alopecia boundaries, region traceability, skin phototype, and CLE-specific validation status.

Transparent documentation of what the automated IHS4 scoring for hidradenitis suppurativa can and cannot do, including the constraints of photograph-based lesion counting and how each limitation is managed.

Transparent documentation of what the AI psoriasis severity scoring can and cannot do, including the inherent constraints of photograph-based PASI assessment and how each limitation is managed.

Automated PASI scoring for psoriasis clinical trials. AI-powered measurement of erythema, desquamation, induration, and affected body surface area across four body regions.

Peer-reviewed publications, conference presentations, key references from the dermatology literature, and the complete clinical validation portfolio supporting acne severity endpoints.

Concrete examples of what sponsors, CROs, and investigators receive from acne severity assessments: per-visit AI reports with lesion detection overlays, longitudinal severity tracking, and structured EDC data exports.

What sponsors, CROs and investigators receive from a cutaneous lupus erythematosus assessment. A per-visit report with real device outputs, the repigmentation signal CLASI-D cannot express, segmentation overlays, and structured EDC export fields.

Item-by-item technical detail on how the AI quantifies the CLASI Activity and CLASI Damage components, the 13-region structure, scale alignment between sign models and CLASI item scales, and how per-image values aggregate into a CLASI score.

Technical deep dive into the acne scoring pipeline, covering inflammatory lesion detection, spatial density computation, IGA calculation, ALADIN composite, multi-perspective scoring, overlap handling, and reproducibility.

Technical detail on the automated PASI pipeline, covering affected-area segmentation, intensity scoring of erythema, desquamation and induration, the PASI formula, the severity scale, and comparison with manual scoring.

Technical detail on how automated lesion detection and counting produce IHS4 and HiSCR for hidradenitis suppurativa, covering lesion classification, the IHS4 formula, severity thresholds, HiSCR against baseline, and comparison with manual assessment.

Technical detail on how pixel-level hair loss segmentation produces the SALT score for alopecia, covering the four scalp quadrants and their weights, the SALT formula, severity bands, responder definitions against baseline, a worked example, and comparison with manual assessment.

Deep technical detail on the automated SCORAD and EASI scoring pipelines, covering BSA segmentation, intensity sign scoring, SCORAD and EASI formulas, severity scale, and comparison with manual assessment.